Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06131632 | Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant Chemotherapy(ConSIBreC) | not yet recruiting | N/A | 300 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT02965950 | The p53 Breast Cancer Trial(p53b) | active not recruiting | Phase 2 | 190 | Haukeland University HospitalOTHER | 1 | Jan 12, 2024 |
| clinicaltrials |
| NCT05993559 | Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy | not yet recruiting | Phase 3 | 1,314 | Gangnam Severance HospitalOTHER | 0 | Jan 12, 2024 | clinicaltrials |
| NCT01717131 | Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node | active not recruiting | N/A | 2,228 | Institut Paoli-CalmettesOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06162559 | Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study(TRAIN-4) | recruiting | Phase 1 | 30 | The Netherlands Cancer InstituteOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06202313 | Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast Cancer | not yet recruiting | Phase 2 | 128 | Shengjing HospitalOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06193122 | Three-Dimensional Ultrasound and Spectroscopy as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment | not yet recruiting | — | 200 | Sunnybrook Health Sciences CentreOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT06193707 | Intelligent Remote Intervention for High-risk Breast Cancer Populations | not yet recruiting | N/A | 1,250 | Qianfoshan HospitalOTHER | 0 | Jan 5, 2024 | clinicaltrials |
| NCT05132790 | Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment | active not recruiting | N/A | 24 | Shengjing HospitalOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT06165900 | Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC | recruiting | Phase 2 | 136 | Shengjing HospitalOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT06185569 | FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy(FREDO-ODX-23) | recruiting | — | 4,500 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT04050228 | Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer | recruiting | N/A | 240 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT01872975 | Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery | active not recruiting | N/A | 1,636 | NSABP Foundation IncNETWORK | 7 | Dec 27, 2023 | clinicaltrials |
| NCT06175078 | Three-Dimensional Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses | not yet recruiting | — | 200 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 27, 2023 | clinicaltrials |
| NCT06001086 | A Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast Cancer | recruiting | Phase 2 | 70 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT05689619 | SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)(SILMET) | recruiting | N/A | 70 | A.O.U. Città della Salute e della ScienzaOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT04050423 | Investigation of Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses | recruiting | — | 1,200 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 14, 2023 | clinicaltrials |
| NCT04134780 | Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response | recruiting | — | 150 | Sunnybrook Health Sciences CentreOTHER | 2 | Dec 14, 2023 | clinicaltrials |
| NCT04428528 | Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant Chemotherapy | recruiting | — | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT06154590 | Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor(NASBP-B-09) | not yet recruiting | — | 100 | DR. DIANE CHISESI NFS. MD. PHD.OTHER | 1 | Dec 4, 2023 | clinicaltrials |
| NCT05451784 | Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS(TILS001) | recruiting | Phase 1 / Phase 2 | 20 | Fundacio Clinic BarcelonaOTHER | 1 | Nov 24, 2023 | clinicaltrials |
| NCT06144346 | Metastases Directed Therapy for Oligometastatic Breast Cancer | recruiting | N/A | 150 | National Cancer Institute, EgyptOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06093022 | Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study(SurMed-BCLM) | recruiting | — | 720 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Nov 14, 2023 | clinicaltrials |
| NCT06126406 | Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors | recruiting | Phase 1 | 60 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06010862 | Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors | recruiting | Phase 1 | 36 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Nov 8, 2023 | clinicaltrials |
| NCT06110845 | CLinical Evaluation Of a comPuter Algorithm To Report BreAst cAncers (CLEOPATRAA)(CLEOPATRAA) | not yet recruiting | — | 800 | The Leeds Teaching Hospitals NHS TrustOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT06104085 | 99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer | recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 27, 2023 | clinicaltrials |
| NCT03561454 | A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System Patients | active not recruiting | — | 100 | MedStar Franklin Square Medical CenterOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT04925856 | Immunomonitoring of Breast Cancer Patients During Systemic Treatment(IMMUNE CAPTURE) | recruiting | N/A | 150 | Centre Georges Francois LeclercOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT04172259 | ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC | active not recruiting | Phase 2 | 156 | Sun Yat-sen UniversityOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT04687956 | Primary Surgical Prevention of Breast Cancer-related Lymphedema(LYMPHA) | recruiting | N/A | 72 | Gangnam Severance HospitalOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT06076772 | Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients | not yet recruiting | — | 54 | Assiut UniversityOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT06073418 | Dietary Habits, Nutritional Knowledge and Physical Activity Assessment in Early Stage Breast Cancer Patients(DEMETRA) | recruiting | — | 1,098 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT03324932 | Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer | active not recruiting | Phase 3 | 160 | Kyoto Prefectural University of MedicineOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT05860907 | Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis | not yet recruiting | Phase 4 | 384 | Fudan UniversityOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT05569811 | NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial(VALENTINE) | active not recruiting | Phase 2 | 120 | SOLTI Breast Cancer Research GroupOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06043466 | A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors | recruiting | Phase 1 | 30 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06028724 | A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)(POPCORN) | recruiting | — | 782 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06035016 | Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer | recruiting | — | 300 | Peking Union Medical College HospitalOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06023277 | A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 40 | Jacinto Convit World Organization Inc.OTHER | 2 | Sep 5, 2023 | clinicaltrials |
| NCT02221999 | Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients(SHPD002) | active not recruiting | Phase 2 / Phase 3 | 250 | RenJi HospitalOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT06015113 | Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis | not yet recruiting | N/A | 20 | Xi'an International Medical Center HospitalOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT06000917 | A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer | recruiting | Phase 2 | 62 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Aug 21, 2023 | clinicaltrials |
| NCT05983094 | Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer | not yet recruiting | Phase 2 | 181 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 9, 2023 | clinicaltrials |
| NCT05980208 | A Real-world Study of Inetetamab for First-line Treatment of MBC | not yet recruiting | — | 150 | Hunan Cancer HospitalOTHER | 0 | Aug 8, 2023 | clinicaltrials |
| NCT05976412 | Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer | recruiting | N/A | 1,355 | Ruijin HospitalOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT05979220 | Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy | not yet recruiting | Phase 2 | 178 | Shuangyue LiuOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT00909909 | Radiation Therapy in Treating Women With Early Stage Breast Cancer | active not recruiting | Phase 2 | 200 | Rutgers, The State University of New JerseyOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04722692 | Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ(SENTINOT_2) | recruiting | Phase 3 | 500 | Uppsala UniversityOTHER | 3 | Aug 3, 2023 | clinicaltrials |
| NCT05975437 | Effectiveness of Personalized Surveillance and Aftercare for Breast Cancer(NABOR) | enrolling by invitation | — | 1,040 | Comprehensive Cancer Centre The NetherlandsOTHER | 1 | Aug 3, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Jan 23, 2024source: clinicaltrials